Sanofi SA
NASDAQ:SNY

  • LAST PRICE
    57.4700
  • TODAY'S CHANGE (%)
    0.5600 (0.9840%)
  • Bid / Lots
    56.6700/ 1
  • Ask / Lots
    58.2000/ 1
  • Open / Previous Close
    57.2800 / 56.9100
  • Day Range
    57.0700
    57.5300
  • 52 Week Range
    42.6300
    58.9700
  • Volume
    1,354,992

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
SNY
Sanofi SA
145.3B
30.8x
+4.55%
PFE
Pfizer Inc
169.0B
-64.1x
-7.10%
GSK
GSK plc
88.2B
16.5x
+6.39%
BMY
Bristol-Myers Squibb Co
100.3B
-15.3x
+4.90%
BAYRY
Bayer AG
30.0B
-21.8x
---
AZN
AstraZeneca PLC
244.2B
38.1x
+17.52%
As of 2024-09-18

Company Information

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Contact Information

Headquarters
46 Avenue de la Grande ArmeePARIS, France 75017
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Frederic Oudea
Chief Executive Officer, Executive Director, Member of the Executive Committee
Paul Hudson
Chief Financial Officer, Member of the Executive Committee
Francois-Xavier Roger
Chief People Officer, Executive Vice President, Member of the Executive Committee
Natalie Bickford
Executive Vice President, General Counsel, Member of the Executive Committee
Roy Papatheodorou

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$145.3B
Revenue (TTM)
$52.7B
Shares Outstanding
2.5B
Dividend Yield
3.54%
Annual Dividend Rate
2.0369 USD
Ex-Dividend Date
05-09-24
Pay Date
06-06-24
Beta
0.57
EPS
$1.87
Book Value
$32.88
P/E Ratio
30.8x
Price/Sales (TTM)
2.8
Price/Cash Flow (TTM)
20.1x
Operating Margin
13.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.